Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Maurer

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Therapeutic Advances in Medical Oncology|December 16, 2024
Random forest algorithm identifies miRNA signatures for breast cancer detection and classification from patient urine samplesJochen Maurer, Matthias Rübner, Chao-Chung Kuo, et al.
Cancers|January 11, 2022
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro StudyRamya Ambur Sankaranarayanan, Jennifer Peil, Andreas T J Vogg, et al.
Plos One|November 19, 2010
Early acquisition of neural crest competence during hESCs neuralizationCarol Lynn Curchoe, Jochen Maurer, Sonja J McKeown, et al.
Cancers|May 13, 2023
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. <i>Cancers</i> 2022, <i>14</i>, 230Ramya Ambur Sankaranarayanan, Jennifer Peil, Andreas T J Vogg, et al.
Breast Cancer Research : BCR|February 20, 2024
The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [<sup>177</sup>Lu]Lu-PSMA-I&T for triple-negative breast cancerAmelie Heesch, Alexandru Florea, Jochen Maurer, et al.
Plos One|July 30, 2011
A Src-Tks5 pathway is required for neural crest cell migration during embryonic developmentDanielle A Murphy, Begoña Diaz, Paul A Bromann, et al.
APL Bioengineering|May 10, 2019
Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancerMohit Kumar Jolly, Bogdan-Tiberius Preca, Satyendra C Tripathi, et al.
Nature Cell Biology|July 29, 2020
A pan-cancer analysis reveals nonstop extension mutations causing SMAD4 tumour suppressor degradationSonam Dhamija, Chul Min Yang, Jeanette Seiler, et al.
International Journal of Cancer|June 17, 2015
A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cellsBogdan-Tiberius Preca, Karolina Bajdak, Kerstin Mock, et al.
Acta Biomaterialia|January 22, 2026
Bioengineering multicellular tumor spheroids with tunable extracellular matrix depositionAlessandro Motta, Rasika Daware, Alessia Nucci, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Therapeutic Advances in Medical Oncology|December 16, 2024
Random forest algorithm identifies miRNA signatures for breast cancer detection and classification from patient urine samplesJochen Maurer, Matthias Rübner, Chao-Chung Kuo, et al.
Cancers|January 11, 2022
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro StudyRamya Ambur Sankaranarayanan, Jennifer Peil, Andreas T J Vogg, et al.
Plos One|November 19, 2010
Early acquisition of neural crest competence during hESCs neuralizationCarol Lynn Curchoe, Jochen Maurer, Sonja J McKeown, et al.
Cancers|May 13, 2023
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. <i>Cancers</i> 2022, <i>14</i>, 230Ramya Ambur Sankaranarayanan, Jennifer Peil, Andreas T J Vogg, et al.
Breast Cancer Research : BCR|February 20, 2024
The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [<sup>177</sup>Lu]Lu-PSMA-I&T for triple-negative breast cancerAmelie Heesch, Alexandru Florea, Jochen Maurer, et al.
Plos One|July 30, 2011
A Src-Tks5 pathway is required for neural crest cell migration during embryonic developmentDanielle A Murphy, Begoña Diaz, Paul A Bromann, et al.
APL Bioengineering|May 10, 2019
Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancerMohit Kumar Jolly, Bogdan-Tiberius Preca, Satyendra C Tripathi, et al.
Nature Cell Biology|July 29, 2020
A pan-cancer analysis reveals nonstop extension mutations causing SMAD4 tumour suppressor degradationSonam Dhamija, Chul Min Yang, Jeanette Seiler, et al.
International Journal of Cancer|June 17, 2015
A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cellsBogdan-Tiberius Preca, Karolina Bajdak, Kerstin Mock, et al.
Acta Biomaterialia|January 22, 2026
Bioengineering multicellular tumor spheroids with tunable extracellular matrix depositionAlessandro Motta, Rasika Daware, Alessia Nucci, et al.
Pageof 6